PRN — Profound Medical Balance Sheet
0.000.00%
- CA$197.15m
- CA$128.17m
- $10.68m
- 55
- 13
- 55
- 35
Annual balance sheet for Profound Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 83.9 | 67.2 | 46.5 | 26.2 | 54.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.43 | 1.41 | 6.34 | 7.29 | 7.04 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 97.7 | 77.1 | 62 | 41.9 | 69.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.28 | 1.9 | 1.72 | 1.57 | 0.821 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 105 | 86.8 | 64.4 | 44 | 70.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.81 | 4.16 | 4.18 | 6.37 | 6.57 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 7.25 | 6.16 | 12.4 | 12.7 | 9.81 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 97.3 | 80.6 | 52 | 31.2 | 60.4 |
Total Liabilities & Shareholders' Equity | 105 | 86.8 | 64.4 | 44 | 70.2 |
Total Common Shares Outstanding |